Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $136.17M | 56,974,913 | 65.77% | 34.23% | Net Selling | Net Buying | ||
| HTFL | HEARTFLOW INC | $2.40B | 85,158,719 | 52.02% | 35.50% | Net Buying | Net Buying | ||
| FBRX | FORTE BIOSCIENCES INC | $401.36M | 12,526,935 | 62.65% | 37.35% | Net Buying | Net Buying | ||
| W | WAYFAIR INC | $11.85B | 130,338,081 | 83.83% | 16.17% | Net Selling | Net Selling | ||
| NBP | NOVABRIDGE BIOSCIENCES | $394.49M | 265,169,373 | 11.20% | 0.00% | ||||
| CNTX | CONTEXT THERAPEUTICS INC | $211.32M | 91,879,177 | 75.06% | 1.43% | Net Buying | |||
| LAKE | LAKELAND INDUSTRIES INC | $93.84M | 9,806,128 | 73.54% | 20.35% | Net Selling | Net Selling | ||
| SYRE | SPYRE THERAPEUTICS INC | $2.49B | 77,592,130 | 71.35% | 28.65% | Net Selling | Net Selling | ||
| BETA | BETA TECHNOLOGIES INC | $4.13B | 229,030,133 | 0.00% | 28.14% | Net Buying | Net Buying | ||
| ZYME | ZYMEWORKS INC | $1.73B | 74,836,534 | 52.53% | 47.47% | Net Buying | Net Selling | ||
| CSTL | CASTLE BIOSCIENCES INC | $1.02B | 29,188,659 | 85.50% | 14.50% | Net Selling | Net Selling | ||
| LBRX | LB PHARMACEUTICALS INC | $535.58M | 25,299,102 | 71.88% | 28.12% | Net Buying | |||
| CEVA | CEVA INC | $496.45M | 24,017,805 | 69.22% | 30.78% | Net Buying | |||
| ZGN | ERMENEGILDO ZEGNA NV | $2.47B | 254,089,368 | 23.18% | 0.00% | ||||
| MARA | MARA HOLDINGS INC | $3.13B | 378,184,353 | 73.45% | 10.48% | Net Selling | Net Selling | ||
| KRRO | KORRO BIO INC | $115.46M | 9,417,295 | 25.63% | 74.37% | ||||
| ABVX | ABIVAX SA | $8.28B | 72,944,298 | 71.24% | 0.00% | ||||
| AKA | AKA BRANDS HOLDING CORP | $117.71M | 10,739,676 | 4.11% | 95.89% | Net Selling | Net Selling | ||
| CHYM | CHIME FINANCIAL INC | $8.14B | 374,577,986 | 56.25% | 32.80% | Net Selling | Net Selling | ||
| TYRA | TYRA BIOSCIENCES INC | $1.64B | 53,372,098 | 62.04% | 37.96% | Net Buying | Net Selling | ||
| CARL | CARLSMED INC | $306.08M | 26,592,908 | 17.53% | 55.25% | Net Buying | |||
| CLFD | CLEARFIELD INC | $421.68M | 13,839,096 | 61.07% | 38.93% | Net Selling | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $175.82M | 59,500,000 | 60.11% | 0.00% | ||||
| IMTX | IMMATICS NV | $1.14B | 121,563,829 | 76.04% | 0.00% | ||||
| CGTX | COGNITION THERAPEUTICS INC | $90.92M | 88,274,258 | 24.09% | 29.34% | Net Selling | Net Selling | ||
| CRVO | CERVOMED INC | $43.21M | 9,252,719 | 2.96% | 97.04% | Net Buying | Net Buying | ||
| KYMR | KYMERA THERAPEUTICS INC | $5.59B | 71,949,027 | 75.15% | 24.85% | Net Buying | Net Buying | ||
| SLDB | SOLID BIOSCIENCES INC | $507.97M | 77,910,239 | 55.21% | 44.79% | Net Buying | Net Selling | ||
| TERN | TERNS PHARMACEUTICALS INC | $3.25B | 90,079,781 | 81.05% | 18.95% | Net Selling | Net Selling | ||
| PCVX | VAXCYTE INC | $7.24B | 130,906,263 | 87.67% | 12.33% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $728.41M | 59,076,259 | 55.52% | 44.48% | Net Buying | Net Selling | ||
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | $182.29M | 23,582,453 | 8.18% | 26.64% | Net Buying | Net Selling | ||
| GHRS | GH RESEARCH PLC | $963.94M | 62,029,395 | 71.79% | 0.00% | ||||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.81B | 68,659,923 | 72.98% | 27.02% | Net Selling | Net Selling | ||
| HELP | CYBIN INC | $146.49M | 23,033,127 | 40.05% | 0.00% | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $197.73M | 32,521,599 | 36.78% | 63.22% | Net Selling | Net Selling | ||
| NTSK | NETSKOPE INC | $5.16B | 393,258,861 | 35.83% | 11.96% | Net Buying | Net Selling | ||
| USAR | USA RARE EARTH INC | $3.12B | 132,638,561 | 23.54% | 29.39% | Net Selling | Net Buying | ||
| MBX | MBX BIOSCIENCES INC | $1.72B | 44,902,302 | 44.21% | 55.79% | Net Buying | |||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.01B | 137,704,548 | 45.44% | 54.56% | Net Selling | Net Buying | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.27B | 65,117,761 | 33.20% | 66.80% | Net Selling | Net Selling | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.55B | 74,681,872 | 55.80% | 43.79% | Net Buying | Net Buying | ||
| BNTX | BIONTECH SE | $26.15B | 240,455,450 | 20.98% | 0.00% | ||||
| LXEO | LEXEO THERAPEUTICS INC | $530.62M | 72,987,327 | 67.63% | 9.87% | Net Selling | Net Selling | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.65B | 59,547,781 | 35.05% | 4.62% | Net Buying | |||
| OKLO | OKLO INC | $10.66B | 156,247,075 | 41.46% | 39.32% | Net Selling | Net Selling | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.16M | 48,540,200 | 32.90% | 67.10% | Net Selling | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.03B | 97,389,279 | 83.26% | 16.74% | Net Selling | Net Selling | ||
| UPB | UPSTREAM BIO INC | $1.59B | 54,038,591 | 70.96% | 29.04% | ||||
| KYTX | KYVERNA THERAPEUTICS INC | $333.73M | 43,796,170 | 43.64% | 56.36% | Net Buying | Net Buying | ||
| ACRV | ACRIVON THERAPEUTICS INC | $53.33M | 31,555,126 | 54.09% | 45.91% | Net Selling | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.26B | 47,661,138 | 75.35% | 24.65% | Net Selling | Net Selling | ||
| CBIO | CRESCENT BIOPHARMA INC | $134.90M | 13,892,516 | 13.39% | 86.61% | Net Buying | Net Buying | ||
| APGE | APOGEE THERAPEUTICS INC | $4.43B | 68,320,229 | 87.21% | 5.60% | Net Selling | Net Selling | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.92B | 87,666,408 | 92.57% | 7.43% | Net Buying | Net Buying | ||
| NRIX | NURIX THERAPEUTICS INC | $1.70B | 102,843,012 | 82.43% | 8.29% | Net Selling | Net Buying | ||
| NAVN | NAVAN INC | $2.75B | 248,644,065 | 0.00% | 100.00% | Net Buying | Net Buying | ||
| PEPG | PEPGEN INC | $337.55M | 68,748,224 | 82.51% | 9.24% | Net Buying | |||
| AIRG | AIRGAIN INC | $55.96M | 11,958,193 | 31.95% | 30.69% | Net Selling | Net Selling | ||
| ANRO | ALTO NEUROSCIENCE INC | $466.00M | 31,066,335 | 53.94% | 21.66% | ||||
| TRVI | TREVI THERAPEUTICS INC | $1.47B | 128,230,134 | 41.41% | 58.59% | Net Buying | Net Buying | ||
| CYRX | CRYOPORT INC | $465.64M | 50,068,904 | 93.54% | 4.57% | Net Buying | Net Selling | ||
| IMRX | IMMUNEERING CORP | $306.06M | 64,569,967 | 40.33% | 21.88% | Net Buying | Net Buying | ||
| CTMX | CYTOMX THERAPEUTICS INC | $960.70M | 169,435,395 | 81.09% | 13.04% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.